Search the Newsreel

Die Publicis-Groupe-Aktie hält bei 99,74 Euro

Weilong’s first-half profit ticks up 4% as signature spicy strip sales fall

Elicio Therapeutics (NASDAQ:ELTX) Announces Earnings Results

Elicio Therapeutics (NASDAQ:ELTX) announced its quarterly earnings, reporting a loss of $0.43 per share, which surpassed analyst estimates by $0.11. Despite a 2.9% rise in shares following the announcement, the stock remains significantly below its 52-week high, with a market capitalization of $60.1 million. …

Elicio Therapeutics (ELTX) faces going-concern risk after $20M loss and trial miss

Elicio Therapeutics reported a net loss of $20.0 million for the first half of 2026 and faces substantial doubt about its ability to continue as a going concern, with existing cash expected to fund operations only into Q1 2027. The company's lead Phase 2 …

Elicio Therapeutics: Q2 Earnings Snapshot

Elicio Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Elicio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

Elicio Therapeutics announced its second-quarter 2026 financial results and provided corporate updates, including plans to initiate a Phase 1 combination study of ELI-002 7P for metastatic pancreatic cancer in Q4 2026, following observations of multiple complete responses. While its Phase 2 AMPLIFY-7P trial did …

ELTX Stock Heads For Worst Day Ever — Elicio Therapeutics' Pancreatic Cancer Data Disappoints

WL Delicious Announces 2026 Interim Results：Rooted in Consumer Needs, Steadily Advancing its Delicious and Healthy Strategy，Interim Payout Ratio Significantly Raised to 90%

Weilong Sets 2026–2028 Dividend Framework to Boost Predictable Shareholder Returns

Weilong Delicious Delivers Higher Interim Revenue, Margins and Dividends

Weilong Delicious Declares Interim Cash Dividend for First Half of 2026

Weilong Delicious Announces Special Mid-Year Cash Dividend

Die Publicis-Groupe-Aktie legt nach starken Halbjahreszahlen zu

Grupo Financiero Galicia SA (GGAL) Shares Fall 4.1% -- GF Value Says Still Overvalued

Grupo Financiero Galicia SA (GGAL) shares dropped 4.1% on August 11, 2026, trading at $44.53. GuruFocus's GF Value indicates that GGAL is significantly overvalued at this price, with a fair value of $25.50. Despite the overvaluation and an unprofitable, cash-flow negative status, insiders have …

Grupo Financiero Galicia SA ADR B Unsponsored Brazilian Depositary Receipt Repr 0.2 ADR B

This article displays financial data for Grupo Financiero Galicia SA ADR B, specifically focusing on its cash flow from financing activities. The content is presented within the TradingView platform context, indicating it is a financial data point for the GGAL34 stock on the B3 …

Elicio Therapeutics Announces Activation of the Investigator-Initiated Phase 1 Study of Neoadjuvant ELI-002 7P for Pancreatic Ductal Adenocarcinoma

Elicio Therapeutics has announced the activation of an investigator-initiated Phase 1 study for its immunotherapy ELI-002 7P, targeting KRAS-driven pancreatic ductal adenocarcinoma (PDAC) in the neoadjuvant setting. The study, conducted by Memorial Sloan Kettering Cancer Center and funded by The Lustgarten Foundation and Break …

Elicio Study to Test Immunotherapy Before Pancreatic Cancer Surgery

Elicio Therapeutics has activated an investigator-initiated Phase 1 study to evaluate its immunotherapy ELI-002 7P in patients with resectable and borderline resectable KRAS-mutant pancreatic ductal adenocarcinoma (PDAC). The study, conducted by Memorial Sloan Kettering Cancer Center and funded by The Lustgarten Foundation and Break …

Publicis-Groupe-Aktie legt vor Quartalszahlen den Fokus auf Marge

GRUPO FINANCIERO GALICIA SA (GGALC.BA) Stock Forum & Discussion

This page is a stock forum and discussion for GRUPO FINANCIERO GALICIA SA (GGALC.BA) on Yahoo Finance. It displays a delayed quote for the stock, showing it trading at 4.5900 USD with a -3.16% change. The content encourages user participation in discussions, moderated according …

GRUPO FINANCIERO GALICIA SA (GGALC.BA) Interactive Stock Chart

This Yahoo Finance page provides an interactive stock chart for GRUPO FINANCIERO GALICIA SA (GGALC.BA), detailing its current trading price, percentage change, and recent news articles. The stock closed at 4.5900 USD, down 3.16%, on August 7. The page also includes links to various …

Noticias de acciones de Grupo Financiero Galicia SA (GGAL)

GRUPO FINANCIERO GALICIA SA (GGALC.BA) latest press releases and corporate news

This Yahoo Finance page provides information on GRUPO FINANCIERO GALICIA SA (GGALC.BA), including its stock summary, current price, and market performance. It indicates that there are currently no news stories or press releases available for the company. The page also features general market data …

Grupo Financiero Galicia SA (GGAL) Stock News Today

GRUPO FINANCIERO GALICIA SA (GGALC.BA) Income Statement

This page provides financial information for GRUPO FINANCIERO GALICIA SA (GGALC.BA), specifically its income statement. However, the income statement data is listed as "Not Available." The page also displays current stock information and links to other financial data and market indices.

Grupo Financiero Galicia SA Unsponsored Brazilian Depositary Receipt Repr 0.2 ADR B Cash Flow

This article presents the cash flow data for Grupo Financiero Galicia SA (GGAL34) for Q1 2026 and previous years, showing operating, investing, and financing activities. Free cash flow for Q1 2026 was BRL 2.73 billion, with operating cash flow for 2025 at BRL 1.06 …

Grupo Financiero Galicia SA (GGAL) Earnings Forecast: Future EPS & Revenue Growth Estimates

Certain Warrants of Elicio Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 6-AUG-2026.

Elicio Therapeutics, Inc. has certain warrants under a lock-up agreement that ends on August 6, 2026. The lock-up period for these warrants began on July 6, 2026, and lasts for 31 days. This agreement restricts officers and directors from selling or disposing of common …

Grupo Financiero Galicia SA's Dividend Analysis

This article first appeared on GuruFocus. Assessing the Sustainability and Growth of GGAL's Upcoming Dividend Payment Grupo Financiero Galicia SA (NASDAQ:GGAL) recently announced a total dividend of $0.05 per share, with the ex-dividend date set for 2026-08-03. This payment includes a $0.05 per share …

Publicis Is Winning the AI Advertising Race, and Its Stock Still Looks Cheap

Publicis is pairing AI-powered marketing with strong client retention, growing free cash flow, and a major data acquisition. Despite outperforming peers, the shares still trade at a discount. Continue Reading

Grupo Financiero Galicia S.A. (NASDAQ:GGAL) Declares Monthly Dividend of $0.05

Grupo Financiero Galicia S.A. (NASDAQ:GGAL) announced a monthly dividend of $0.0531 per share, payable on August 10th to shareholders of record on August 3rd. This dividend implies an annualized yield of 1.3% and is well-covered by earnings, with a current payout ratio of 7% …

Grupo Financiero Galicia SA Class B Revenue Breakdown – BCBA:GGAL

Grupo Financiero Galicia SA Class B (GGAL) reported total revenue of 8.45 trillion ARS last year, with its Bank segment being the primary contributor at 6.14 trillion ARS. The majority of this revenue, 9.29 trillion ARS, originated from Argentina. These figures highlight the company's …

Die Publicis-Groupe-Aktie legt nach soliden Quartalszahlen zu